{"api":"v1","generated_at":"2026-10-01T10:18:30.432Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-vte-bleed-a8a2aa","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-vte-bleed-a8a2aa/at/2026-10-01T05-50Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-10-01T05:50:06.230Z","snapshot_stamp":"2026-10-01T05-50Z","endpoint":{"slug":"api-magentlab-com-api-calc-vte-bleed-a8a2aa","canonical_url":"https://api.magentlab.com/api/calc/vte_bleed","resource":"https://api.magentlab.com/api/calc/vte_bleed","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"Klok 2016 VTE-BLEED for major bleeding on stable anticoagulation after VTE. Six items: active cancer 2; male with uncontrolled hypertension (SBP ≥140) 1; anemia 1.5; history of bleeding 1.5; age ≥60 1.5; renal dysfunction (eGFR/CrCl <60) 1.5; max 9. Low <2, high ≥2. Caller-assigned flags; magent does not assay hemoglobin or eGFR. Not a medical device, not HAS-BLED, and not a treatment-duration order.","service_name":"magent","declared_category":null,"declared_tags":["vte-bleed","vte","bleeding","anticoagulation"],"route_template":null,"registry_updated":"2026-09-28T14:27:38.421Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc vte bleed","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-10-01T05:50:06.230Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-10-01T05:50:06.230Z","calls_30d":1,"unique_payers_30d":1,"last_called_at":"2026-09-28T14:27:38.244Z"},"validation":{"latest":{"observed_at":"2026-10-01T08:52:28.128Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-10-01"},"uptime":[{"days":7,"observed":5,"passed":5,"ratio":1},{"days":30,"observed":5,"passed":5,"ratio":1},{"days":90,"observed":5,"passed":5,"ratio":1}],"history_90d":[{"observed_at":"2026-10-01T08:52:28.128Z","state":"pass","failed_checks":[],"run_id":"daily-2026-10-01","state_changed":false},{"observed_at":"2026-09-30T08:17:04.062Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T20:26:25.636Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T17:34:46.865Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-28","state_changed":false},{"observed_at":"2026-09-28T16:46:40.952Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["vte-bleed","vte","bleeding","anticoagulation"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/vte_bleed","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T14:27:38.244Z","l30DaysTotalCalls":1,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/vte_bleed","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"age":70,"sex":"male","anemia":false,"active_cancer":false,"renal_dysfunction":false,"history_of_bleeding":false,"uncontrolled_hypertension":false},{"age":70,"sex":"male","anemia":false,"active_cancer":false,"renal_dysfunction":false,"history_of_bleeding":false,"uncontrolled_hypertension":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/vte_bleed","count":2,"items":[{"sex":"male","score":1.5,"formula":"vte_bleed","citation":{"id":"klok-2016","doi":"10.1183/13993003.00280-2016","pmid":"27471209","title":"Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment","source":"Eur Respir J. 2016;48(5):1369-1376","authors":"Klok FA, Hösel V, Clemens A, Yollo WD, Tilke C, Schulman S, Lankeit M, Konstantinides SV"},"age_years":70,"max_score":9,"components":[{"factor":"active_cancer","points":0,"present":false},{"sex":"male","factor":"male_uncontrolled_hypertension","points":0,"present":false,"uncontrolled_hypertension":false},{"factor":"anemia","points":0,"present":false},{"factor":"history_of_bleeding","points":0,"present":false},{"value":70,"factor":"age_ge_60","points":1.5,"present":true},{"factor":"renal_dysfunction","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","vte_bleed_band":"low","formula_expression":"VTE-BLEED = active_cancer 2 + (male AND uncontrolled_hypertension) 1 + anemia 1.5 + history_of_bleeding 1.5 + age_ge_60 1.5 + renal_dysfunction 1.5; Klok 2016; max 9; low <2, high >=2"},{"sex":"male","score":1.5,"formula":"vte_bleed","citation":{"id":"klok-2016","doi":"10.1183/13993003.00280-2016","pmid":"27471209","title":"Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment","source":"Eur Respir J. 2016;48(5):1369-1376","authors":"Klok FA, Hösel V, Clemens A, Yollo WD, Tilke C, Schulman S, Lankeit M, Konstantinides SV"},"age_years":70,"max_score":9,"components":[{"factor":"active_cancer","points":0,"present":false},{"sex":"male","factor":"male_uncontrolled_hypertension","points":0,"present":false,"uncontrolled_hypertension":false},{"factor":"anemia","points":0,"present":false},{"factor":"history_of_bleeding","points":0,"present":false},{"value":70,"factor":"age_ge_60","points":1.5,"present":true},{"factor":"renal_dysfunction","points":0,"present":false}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","vte_bleed_band":"low","formula_expression":"VTE-BLEED = active_cancer 2 + (male AND uncontrolled_hypertension) 1 + anemia 1.5 + history_of_bleeding 1.5 + age_ge_60 1.5 + renal_dysfunction 1.5; Klok 2016; max 9; low <2, high >=2"}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["age","sex","active_cancer","uncontrolled_hypertension","anemia","history_of_bleeding","renal_dysfunction"],"properties":{"age":{"type":"integer","description":"Age in years (18-120). Age ≥60 scores 1.5 (Klok 2016). magent does not assign age."},"sex":{"enum":["female","male"],"type":"string","description":"female or male. Uncontrolled hypertension scores 1 only when sex is male (Klok 2016 / XALIA SBP ≥140 item). Female never scores that item."},"anemia":{"type":"boolean","description":"Anemia as assigned by the caller (Klok 2016: hemoglobin <130 g/L in men or <120 g/L in women). true scores 1.5. magent does not take a hemoglobin number."},"active_cancer":{"type":"boolean","description":"Active cancer as assigned by the caller (Klok 2016). true scores 2. magent does not diagnose cancer."},"renal_dysfunction":{"type":"boolean","description":"Renal dysfunction (eGFR or CrCl <60) as assigned by the caller (Klok 2016). true scores 1.5. magent does not compute eGFR or creatinine clearance."},"history_of_bleeding":{"type":"boolean","description":"History of bleeding as assigned by the caller (Klok 2016). true scores 1.5. magent does not grade bleeding."},"uncontrolled_hypertension":{"type":"boolean","description":"Uncontrolled hypertension (SBP ≥140 mmHg) as assigned by the caller (Klok 2016 / XALIA). true scores 1 only in males; females score 0 even when true. magent does not measure blood pressure."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"Klok 2016 VTE-BLEED for major bleeding on stable anticoagulation after VTE. Six items: active cancer 2; male with uncontrolled hypertension (SBP ≥140) 1; anemia 1.5; history of bleeding 1.5; age ≥60 1.5; renal dysfunction (eGFR/CrCl <60) 1.5; max 9. Low <2, high ≥2. Caller-assigned flags; magent does not assay hemoglobin or eGFR. Not a medical device, not HAS-BLED, and not a treatment-duration order.","lastUpdated":"2026-09-28T14:27:38.421Z","serviceName":"magent","x402Version":2}]}}